Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.78 USD | +2.41% |
|
+0.68% | +10.91% |
03:38pm | TD Cowen Raises Price Target on Ovintiv to $66 From $64, Maintains Buy Rating | MT |
May. 22 | Ovintiv Maintained at Buy at TPH as It Models Second-Quarter Results; Price Target at US$67.00 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.93% | 12.71B | |
+5.91% | 288B | |
+63.46% | 134B | |
-2.02% | 131B | |
+12.96% | 75.26B | |
+0.77% | 69.07B | |
+1.11% | 52.74B | |
+3.46% | 45.31B | |
-12.40% | 34.01B | |
+25.06% | 33.94B |
- Stock Market
- Equities
- OVV Stock
- News Ovintiv Inc.
- Ovintiv Maintained at Buy at TPH Following First-Quarter Results; Price Target at US$66.00